Capital raising strategy: the terms that shape your business

I regard capital raising strategy as a decision about future obligations, not simply a search for available money. A funding proposal can look attractive on valuation and still leave a business poorly equipped for its next difficult decision. Before comparing offers, I want to understand what each investor will expect, what the company must deliver and who will have authority when the original plan needs to change.

That matters to founders seeking growth, boards approving a transaction and family offices investing their own capital. Each may enter negotiations with a different understanding of the relationship. The purpose of a well-structured deal is not to eliminate those differences. It is to make them explicit while there is still room to negotiate.

Capital raising strategy starts with the business requirement

I would begin with a question that is often answered too loosely: what, precisely, must this capital enable? Funding an acquisition, building a sales team and financing working capital create different demands. They should not automatically be financed through the same instrument or on the same timetable.

The answer needs to include the period before the investment produces cash, the uncertainty around that period and the consequences of delay. A business funding an unproven expansion needs room to learn. A business financing contracted activity may have a more predictable requirement, although collection risk still matters.

Only then would I consider the appropriate balance of equity, debt or other structures. Starting with an investor’s preferred product reverses the process. It encourages the company to adapt its plan to the financing rather than select financing that supports a credible plan.

Compare the obligations behind the headline price

Valuation is visible and easy to discuss. The wider economic bargain takes more work. For equity, that includes preference rights, dilution provisions and the distribution of proceeds on an exit. For debt, it includes fees, security, repayment requirements, covenants and any restrictions on deploying cash.

A higher valuation does not necessarily produce a better outcome for existing shareholders. A preference structure may allocate proceeds very differently from the ownership percentages presented at completion. Equally, a lower interest rate may offer limited comfort if repayment begins before the funded activity can reasonably generate cash.

I want the board to see these effects in straightforward scenarios: performance broadly on plan, performance below plan and a sale at a disappointing value. The point is not to forecast every outcome. It is to identify where apparently modest drafting choices materially change the allocation of value or control.

Understand who can actually make decisions

Investor fit requires more than agreement with the person leading the discussions. I want to know who approves the investment, who can authorise further funding and who decides whether to support a revised business plan. Those may be different people, operating under different constraints.

This is particularly important with family offices, whose arrangements vary considerably. Direct access to a principal can support decisive action, but it does not remove the need to understand delegated authority, investment governance or how decisions continue during an absence or succession.

Founders should also distinguish enthusiasm from capacity. An investor may like the business without being able to participate in a later round. That is not necessarily a reason to decline the investment. It is a reason not to build the financing plan around an untested assumption of continuing support.

Negotiate governance around real decisions

Governance terms should reflect the decisions the business is likely to face. Reserved matters can protect investors against fundamental changes, but an extensive consent regime can also turn routine management into a negotiation. The distinction between oversight and operational approval needs careful attention.

I would test the proposed arrangements against practical questions:

• Can management adjust spending within an approved budget without seeking fresh consent?
• Who must approve a necessary financing if the company is behind plan?
• What happens if an investor does not respond within the required period?
• How are conflicts handled when an investor proposes to provide additional capital?

Board representation also deserves precision. A director nominated by an investor must understand the duties attached to that office under the relevant law; the role is not simply to transmit shareholder instructions. Information rights, consent rights and board responsibilities should be designed as distinct mechanisms, not treated as interchangeable forms of protection.

Discuss underperformance before signing

The most useful negotiation may concern what happens when the business misses its plan. I would rather have that discussion before completion, when both sides can consider the issue without an immediate cash shortage shaping their judgement.

For a founder, the questions include whether a missed milestone changes funding availability, whether further investment requires a new valuation and whether remedial action can be agreed without paralysing operations. For an investor, they include the quality of reporting, the speed of disclosure and the board’s willingness to revise assumptions.

Neither side should mistake a constructive conversation for a binding commitment. Where continued funding or a particular remedy is essential, it needs appropriate documentation. Where an outcome remains discretionary, the company should recognise that discretion and maintain an alternative plan.

Leave room for the next transaction

Every financing becomes part of the starting position for the next one. Rights that appear manageable today may complicate a later investment, refinancing or sale. Multiple consent thresholds, incompatible preferences and poorly defined participation rights can make a sound business unnecessarily difficult to finance.

I therefore want advisers to assess not only whether the current deal can complete, but also how its terms would operate alongside a future investor. That does not mean stripping out legitimate protections. It means understanding their cumulative effect and avoiding provisions whose consequences neither party has properly considered.

The same discipline applies to reporting. Commitments should provide useful visibility without requiring a finance function the business cannot yet sustain. If more sophisticated reporting is necessary, the cost and implementation timetable belong in the funding plan.

Make the recommendation explicit

A board paper recommending a capital raise should explain more than the amount secured and the headline price. I would expect it to identify the alternatives considered, the obligations accepted, the principal downside scenarios and the decisions that will require investor consent. It should also state which assumptions remain unverified.

There is rarely a financing proposal without compromise. The board’s responsibility is to judge whether those compromises are proportionate to what the capital enables. I would support a transaction when the business can meet its obligations under a credible range of outcomes, and when both sides understand how decisions will be made if it cannot. That is a more demanding test than whether the money is available, but it is the test that should determine the recommendation.